CTKB vs UBER · rev $200.5M vs P/E 18, rev $52.02B
Cytek Biosciences Inc (CTKB) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported CTKB revenue for 2024-12-31 was $200.5M. Net income was -$6.0M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. CTKB currently screens at market cap $421.8M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
CTKB currently screens at market cap $421.8M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the CTKB and UBER stock pages for the full models.
Not investment advice.